Amgen Looks To Duck Regeneron's Bundling Suit
Pharmaceutical giant Amgen asked a Delaware federal court to throw out a suit from competitor Regeneron alleging that Amgen used a bundling scheme to boost its own cholesterol medication sales while...To view the full article, register now.
Already a subscriber? Click here to view full article